Long-Term Surgical Outcomes and Possible Postoperative Complication with Severe Corneal Endothelial Cell Loss After Trabeculectomy for Cytomegalovirus-Associated Anterior Uveitis with Secondary Glaucoma

References

• van Boxtel LAA, van der Lelij A, van der Meer J, Los LI. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmol. 2007;114(7):1358–1362. doi:10.1016/j.ophtha.2006.09.035.
   PubMed Web of Science ®Google Scholar
• de Schryver I, Rozenberg F, Cassoux N, et al. Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br J Ophthalmol. 2006;90(7):852–855. doi:10.1136/bjo.2005.086546.
   PubMed Web of Science ®Google Scholar
• Chee SP, Jap A. Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol. 2010;94(12):1648–1652. doi:10.1136/bjo.2009.167767.
   PubMed Web of Science ®Google Scholar
• Teoh S-B, Thean L, Koay E. Cytomegalovirus in aetiology of Posner-Schlossman syndrome: evidence from quantitative polymerase chain reaction. Eye (Lond). 2005;19(12):1338–1340. doi:10.1038/sj.eye.6701757.
   PubMed Web of Science ®Google Scholar
• Su CC, Hu FR, Wang TH, et al. Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy. Am J Ophthalmol. 2014;158(5):1024–1031. doi:10.1016/j.ajo.2014.08.007.
   PubMed Web of Science ®Google Scholar
• Chee SP, Jap A. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146(6):883–889. doi:10.1016/j.ajo.2008.09.001.
   PubMed Web of Science ®Google Scholar
• Accorinti M, Gilardi M, Pirraglia MP, et al. Cytomegalovirus anterior uveitis: long-term follow-up of immunocompetent patients. Graefe’s Arch Clin Exp Ophthalmol. 2014;252(11):1817–1824. doi:10.1007/s00417-014-2782-4.
   PubMed Web of Science ®Google Scholar
• Pahlitzsch M, Torun N, Gonnermann J, et al. Trabeculectomy ab interno (trabectome): yet another possibility in the treatment of uncontrolled glaucomatocyclitic crisis under systemic valganciclovir therapy? Eye. 2015;29(10):1335–1339. doi:10.1038/eye.2015.112.
   PubMed Web of Science ®Google Scholar
• Murata K, Ishida K, Ozawa K, Sawada A, Mochizuki K, Yamamoto T. The characteristics of Posner-Schlossman syndrome: a comparison in the surgical outcome between cytomegalovirus-positive and cytomegalovirus-negative patients. Medicine. 2019;98(48):e18123. doi:10.1097/MD.0000000000018123.
   PubMed Web of Science ®Google Scholar
• Murai Y, Mori S, Takano F, et al. The beneficial impact of filtration surgery on antiviral therapy cessation in patients with cytomegalovirus-related secondary glaucoma. BMC Ophthalmol. 2021;21(1):1–8. doi:10.1186/s12886-021-02155-3.
   PubMed Web of Science ®Google Scholar
• Wong MOM, Yu AHY, Chan CKM. Two year outcomes of trabeculectomy in cytomegalovirus anterior uveitis with uncontrolled intraocular pressure. Ocul Immunol Inflamm. August, 2022:1–7. doi:10.1080/09273948.2022.2103828.
   Web of Science ®Google Scholar
• Maruyama K, Maruyama Y, Sugita S, et al. Characteristics of cases needing advanced treatment for intractable Posner–Schlossman syndrome. BMC Ophthalmol. 2017;17(1):45. doi:10.1186/s12886-017-0438-y.
   PubMedGoogle Scholar
• Koizumi N, Suzuki T, Uno T, et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology. 2008;115(2):292–297.e3. doi:10.1016/j.ophtha.2007.04.053.
   PubMed Web of Science ®Google Scholar
• Koizumi N, Inatomi T, Suzuki T, et al. Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study. Br J Ophthalmol. 2015;99(1):54–58. doi:10.1136/bjophthalmol-2013-304625.
   PubMed Web of Science ®Google Scholar
• Kaburaki T, Koshino T, Kawashima H, et al. Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. Eye (Lond). 2009;23(7):1509–1517. doi:10.1038/eye.2009.117.
   PubMed Web of Science ®Google Scholar
• Iwao K, Inatani M, Seto T, et al. Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma. J Glaucoma. 2014;23(2):88–94. doi:10.1097/IJG.0b013e3182685167.
   PubMed Web of Science ®Google Scholar
• Wadke V, Lingam V, George R, et al. Phacotrabeculectomy in eyes with uveitic glaucoma: a retrospective case-control study. J Glaucoma. 2019;28(7):606–612. doi:10.1097/IJG.0000000000001276.
   PubMed Web of Science ®Google Scholar
• Kanaya R, Kijima R, Shinmei Y, et al. Surgical outcomes of trabeculectomy in uveitic glaucoma: a long-term, single-center, retrospective case-control study. J Ophthalmol. 2021;2021:5550776. doi:10.1155/2021/5550776.
   PubMed Web of Science ®Google Scholar
• Broadway DC, Chang LP. Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma. 2001;10(3):237–249. doi:10.1097/00061198-200106000-00017.
   PubMed Web of Science ®Google Scholar
• Hamanaka T, Takei A, Takemura T, Oritsu M. Pathological study of cases with secondary open-angle glaucoma due to sarcoidosis. Am J Ophthalmol. 2002;134(1):17–26. doi:10.1016/S0002-9394(02)01507-6.
   PubMed Web of Science ®Google Scholar
• Shimizu A, Maruyama K, Yokoyama Y, Tsuda S, Ryu M, Nakazawa T. Characteristics of uveitic glaucoma and evaluation of its surgical treatment. Clin Ophthalmol. 2014;8:2383–2389. doi:10.2147/OPTH.S72383.
   PubMedGoogle Scholar
• Wilkins M, Indar A, Wormald R. Intraoperative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev. 2005;2010(2). doi:10.1002/14651858.CD002897.pub2.
   Google Scholar
• Maquet JA, Dios E, Aragón J, Bailez C, Ussa F, Laguna N. Protocol for mitomycin C use in glaucoma surgery. Acta Ophthalmol Scand. 2005;83(2):196–200. doi:10.1111/j.1600-0420.2005.00437.x.
   PubMedGoogle Scholar
• Jampel HD, Solus JF, Tracey PA, et al. Outcomes and bleb-related complications of trabeculectomy. Ophthalmology. 2012;119(4):712–722. doi:10.1016/j.ophtha.2011.09.049.
   PubMed Web of Science ®Google Scholar
• Al Habash A, Aljasim LA, Owaidhah O, Edward DP. A review of the efficacy of mitomycin C in glaucoma filtration surgery. Clin Ophthalmol. 2015;9:1945–1951. doi:10.2147/OPTH.S80111.
   PubMedGoogle Scholar
• Sihota R, Angmo D, Chandra A, Gupta V, Sharma A, Pandey RM. Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma. Graefe’s Arch Clin Exp Ophthalmol. 2015;253(7):1153–1159. doi:10.1007/s00417-015-3028-9.
   PubMed Web of Science ®Google Scholar
• Seol BR, Lee SY, Kim YJ, Kim YK, Jeoung JW, Park KH. Comparison of the efficacy and safety of trabeculectomy with mitomycin c according to concentration: a prospective randomized clinical trial. J Clin Med. 2021;10(1):1–16. doi:10.3390/jcm10010059.
   Web of Science ®Google Scholar
• Choi JA, Kim KS, Jung Y, Park HYL, Park CK. Cytomegalovirus as a cause of hypertensive anterior uveitis in immunocompetent patients. J Ophthalmic Inflamm Infect. 2016;6(1):32. doi:10.1186/s12348-016-0100-5.
   PubMedGoogle Scholar
• Pastor SA, Williams R, Hetherington J, Hoskins HD, Goodman D. Corneal endothelial cell loss following trabeculectomy with mitomycin C. J Glaucoma. 1993;2(2):112–113. doi:10.1097/00061198-199300220-00008.
   PubMedGoogle Scholar
• Arnavielle S, Lafontaine PO, Bidot S, Creuzot-Garcher C, D’athis P, Bron AM. Corneal endothelial cell changes after trabeculectomy and deep sclerectomy. J Glaucoma. 2007;16(3):324–328. doi:10.1097/IJG.0b013e3180391a04.
   PubMed Web of Science ®Google Scholar
• Storr-Paulsen T, Norregaard JC, Ahmed S, Storr-Paulsen A. Corneal endothelial cell loss after mitomycin C-augmented trabeculectomy. J Glaucoma. 2008;17(8):654–657. doi:10.1097/IJG.0b013e3181659e56.
   PubMed Web of Science ®Google Scholar
• Casini G, Loiudice P, Pellegrini M, et al. Trabeculectomy versus EX-PRESS shunt versus Ahmed valve implant: short-term effects on corneal endothelial cells. Am J Ophthalmol. 2015;160(6):1185–1190.e1. doi:10.1016/j.ajo.2015.08.022.
   PubMed Web of Science ®Google Scholar
• Kim MS, Kim KN, Kim C-S. Changes in corneal endothelial cell after Ahmed glaucoma valve implantation and trabeculectomy: 1-year follow-up. Korean J Ophthalmol. 2016;30(6):416–425. doi:10.3341/kjo.2016.30.6.416.
   PubMedGoogle Scholar
• Hirooka K, Nitta E, Ukegawa K, Sato S, Kiuchi Y. Effect of trabeculectomy on corneal endothelial cell loss. Br J Ophthalmol. 2020;104(3):376–380. doi:10.1136/bjophthalmol-2018-313417.
   PubMed Web of Science ®Google Scholar
• Igarashi N, Honjo M, Kaburaki T, Aihara M. Effects of ROCK inhibitors on apoptosis of corneal endothelial Cells in CMV-positive Posner-Schlossman syndrome patients. Invest Ophthalmol Vis Sci. 2020;61(10):5. doi:10.1167/iovs.61.10.5.
   PubMed Web of Science ®Google Scholar
• Okumura N, Okazaki Y, Inoue R, et al. Effect of the Rho-associated kinase inhibitor eye drop (Ripasudil) on corneal endothelial wound healing. Invest Ophthalmol Vis Sci. 2016;57(3):1284–1292. doi:10.1167/iovs.15-18586.
   PubMed Web of Science ®Google Scholar
• Okumura N, Fujii K, Kagami T, et al. Activation of the Rho/Rho kinase signaling pathway is involved in cell death of corneal endothelium. Invest Ophthalmol Vis Sci. 2016;57(15):6843–6851. doi:10.1167/iovs.16-20123.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Yokokura S, Hariya T, Kobayashi W, Hashimoto K, Nakazawa T. Ripasudil eyedrops ameliorated bullous keratopathy complicated with cytomegalovirus corneal endotheliitis: a case report. Ocul Immunol Inflamm. 2021;31(1):1–4. doi:10.1080/09273948.2021.1988114.
   Web of Science ®Google Scholar